Press Releases

November 14, 2022

VIVO Cannabis Announces Third Quarter 2022 Results

Net revenue for Q3 2022 was $6.2 million, a 19% increase from prior quarter International sales reach $2.5 million Beacon Medical continues to be the leading medical cannabis flower brand in Australia The Company entered into a third supplement to the indenture for its debentures to extend their maturity to 2024 Subsequent to the quarter-end, […]

Read More

October 3, 2022

VIVO Cannabis Announces Third Supplemental Debenture Indenture

Toronto, Ontario–(Newsfile Corp. – October 3, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) is pleased to announce that, further to the Company’s news release of September 19, 2022, the Company has entered into a third supplemental debenture indenture dated September 29, 2022 (the “Supplemental Indenture“) with TSX Trust Company […]

Read More

September 19, 2022

VIVO Cannabis Announces Agreement to Amend Outstanding Debentures

Toronto, Ontario–(Newsfile Corp. – September 19, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February 28, 2018 in the aggregate principal amount of $5,546,808 (collectively, the “Debentures“) to amend […]

Read More

August 15, 2022

VIVO Cannabis Announces Second Quarter 2022 Results

Net revenue for Q2 2022 was $5.2 million Company announced that Canna Farms received a Research Licence from Health Canada in June, 2022 Canadian Launch of Fireside™ Pink Kush and Girl Scout Cookies Full-Spectrum 510 Vapes Australian sales delayed due to new regulatory requirements Company announces cost savings workforce reductions focused on its Hope, BC […]

Read More

July 22, 2022

VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada

Toronto, Ontario–(Newsfile Corp. – July 22, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”), ABcann Medicinals Inc., today announced that Canna Farms has […]

Read More

July 1, 2022

VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

Toronto, Ontario–(Newsfile Corp. – July 2, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting"). As announced this morning, at the Meeting, shareholders […]

Read More

June 3, 2022

VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric Research: Anxiety & Depression Outcomes in Medical Cannabis Patients

Toronto, Ontario–(Newsfile Corp. – June 3, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”), ABcann Medicinals Inc., today announced results from its first […]

Read More

May 16, 2022

VIVO Cannabis Announces First Quarter 2022 Results

Net revenue for Q1 2022 was $6.9 million VIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenue Canadian Launch of Canna Farms Single-strain Oils, Infused Pre-rolls, Top Cola Signature Series and Fireside CBD Canna Bliss 510 Vape Cartridge and 10 pack CBD Chocolates Harvest Medicine study on medical cannabis […]

Read More

March 31, 2022

VIVO Cannabis Announces Fourth Quarter 2021 Results

Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million. In February 2021, closed a $7.2 million equity raise to help fund VIVO’s growth In July 2021, the Company elected a new Board of Directors, announced the appointment of Ray Laflamme as CEO and Chairman of the Board and later […]

Read More

February 11, 2022

VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace

Toronto, Ontario–(Newsfile Corp. – February 11, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced a partnership with […]

Read More

VIVO is a family of premium brands and businesses, building a world-class cannabis company through the acquisition and development of specialty brands.